0001246360-14-002136.txt : 20140421 0001246360-14-002136.hdr.sgml : 20140421 20140421161409 ACCESSION NUMBER: 0001246360-14-002136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140417 FILED AS OF DATE: 20140421 DATE AS OF CHANGE: 20140421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szyman Catherine M CENTRAL INDEX KEY: 0001438538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 14774019 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY MSLC310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-04-17 false 0000064670 MEDTRONIC INC MDT 0001438538 Szyman Catherine M 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false SrVP & Pres Diabetes Common Stock 2014-04-17 4 M false 6960 35.92 A 28562.299 D Common Stock 2014-04-17 4 M false 9241 48.7 A 37803.299 D Common Stock 2014-04-17 4 M false 13219 56.74 A 51022.299 D Common Stock 2014-04-17 4 S false 29420 58.7872 D 21602.299 D Employee Stock Option (right to buy) 35.92 2014-04-17 4 M false 6960 0 D 2010-08-03 2019-08-03 Common Stock 6960 0 D Employee Stock Option (right to buy) 48.7 2014-04-17 4 M false 9241 0 D 2007-10-30 2016-10-30 Common Stock 9241 0 D Employee Stock Option (right to buy) 56.74 2014-04-17 4 M false 13219 0 D 2006-10-19 2015-10-19 Common Stock 13219 0 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. This balance increased by 60 shares due to exempt transactions such as dividend reinvestment or Employee Stock Purchase Plan. The exercises and sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.36 to $59.17, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Rhonda L. Ingalsbe, Attorney-in-fact 2014-04-21